Sandra Boström Frithiof

Sandra Boström Frithiof discloses dealings in Calliditas Therapeutics AB to Finansinspektionen. Over a trading history stretching from 1 July 2024 to 2 July 2024, the count stands at 3 filings.

On the open market, the record shows 1 purchase and 2 sales worth €220k. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

On 3 July 2024 came the latest disclosure, an open-market purchase in Calliditas Therapeutics AB. Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.